Fund · Xtrackers MSCI EAFE High Dividend Yield Equity ETF · measured from SEC filings
HDEF holdings
HDEF reports 121 holdings and behaves like 41.3 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-05-29. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.
Measured concentration
as of 2026-05-29Read this figure with the following in mind
2.3% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 41.6
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 24 issuer countries.
What stands out
as of 2026-05-29HDEF's largest investment is Roche Holding AG Chf0.001 at 5.02% of net assets. Nestle' Sa/ag Chf0.10 (regd) and Novartis AG Chf0.49 (regd) follow; the three together are 15%. Ten companies are 41.71% of the fund; the other 111 share the rest. Among the 721 equity funds measured here, HDEF behaves like 41.3 holdings against a median of 42.4 — close to the median. Across 27 quarterly filings HDEF has held roughly steady since 2019-11-29 (46.4 then, 41.3 now). Between the 2026-02-27 and 2026-05-29 filings 19 positions were added and 20 dropped; 16.0% of the weight moved. Switzerland is the largest country at 20.07% of the portfolio, across 24 countries in the filing.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
27Between 2019-11-29 and 2026-05-29, HDEF went from behaving like 46.4 equally weighted positions to 41.3 — 11% fewer, while its top ten went from 39.17% to 41.71% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-05-29 | 121 | 41.3 | 41.71% | 5.09% |
| 2026-02-27 | 122 | 39.5 | 42.78% | 5.89% |
| 2025-11-28 | 126 | 41.2 | 41.87% | 5.26% |
| 2025-08-29 | 118 | 40.2 | 42.82% | 5.31% |
| 2025-05-30 | 118 | 40.3 | 42.22% | 5.09% |
| 2025-02-28 | 114 | 42.2 | 40.07% | 5.27% |
| 2024-11-29 | 114 | 43.5 | 39.66% | 5.07% |
| 2024-08-30 | 117 | 39.7 | 42.07% | 6.3% |
Earlier filings (19 more, back to 2019-11-29)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-05-31 | 121 | 42.2 | 41.17% | 4.87% |
| 2024-02-29 | 123 | 46.2 | 38.09% | 5.19% |
| 2023-11-30 | 126 | 45.2 | 38.93% | 5.08% |
| 2023-08-31 | 116 | 42.6 | 40.34% | 5.08% |
| 2023-05-31 | 118 | 43.6 | 39.7% | 4.97% |
| 2023-02-28 | 113 | 45.7 | 38.12% | 4.85% |
| 2022-11-30 | 115 | 44.7 | 38.67% | 5.09% |
| 2022-08-31 | 117 | 47.6 | 37.17% | 5.2% |
| 2022-05-31 | 120 | 45.2 | 38.94% | 4.94% |
| 2022-02-28 | 114 | 41.5 | 40.25% | 6.05% |
| 2021-11-30 | 118 | 44.8 | 37.71% | 5.1% |
| 2021-08-31 | 108 | 39.5 | 42.24% | 6.08% |
| 2021-05-28 | 109 | 40.2 | 41.9% | 5.18% |
| 2021-02-26 | 116 | 43.4 | 39.41% | 5.19% |
| 2020-11-30 | 121 | 41 | 41.24% | 6.27% |
| 2020-08-31 | 120 | 43.9 | 40.95% | 5.53% |
| 2020-05-29 | 121 | 44 | 40.81% | 5.08% |
| 2020-02-28 | 120 | 45.8 | 39.41% | 5.6% |
| 2019-11-29 | 122 | 46.4 | 39.17% | 5.14% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
2.31% collateralHDEF's filing lists 122 positions including 2.31% of net assets in securities-lending cash collateral. Counted as filed the fund reads 41.6 effective holdings with a top ten of 41.12%; on its own investments — the figure above — it reads 41.3 with a top ten of 41.71%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-05-29The 15 largest of 121 positions in HDEF's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: HDEF.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | ROCHE HOLDING AG | 5.09% | 5.1% |
| 2 | NESTLE' SA/AG | 5.06% | 10.2% |
| 3 | NOVARTIS AG | 5.05% | 15.2% |
| 4 | SHELL PLC | 4.82% | 20.0% |
| 5 | TOTALENERGIES SE | 4.27% | 24.3% |
| 6 | ALLIANZ SE | 4.19% | 28.5% |
| 7 | NOVO NORDISK A/S | 3.65% | 32.1% |
| 8 | IBERDROLA SA | 3.42% | 35.6% |
| 9 | BRITISH AMERICAN TOBACCO PLC | 3.08% | 38.6% |
| 10 | UNILEVER PLC | 3.07% | 41.7% |
| 11 | ZURICH INSURANCE GROUP AG | 2.64% | 44.3% |
| 12 | DBS GROUP HOLDINGS LTD | 2.51% | 46.9% |
| 13 | SANOFI SA | 2.38% | 49.2% |
| 14 | NATIONAL GRID PLC | 1.99% | 51.2% |
| 15 | AXA SA | 1.80% | 53.0% |
By country of issuer
as of 2026-05-29Share of HDEF's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| Switzerland | 20.53% |
| United Kingdom | 17.71% |
| France | 13.31% |
| Germany | 9.13% |
| Japan | 7.82% |
| Singapore | 5.69% |
| Spain | 4.59% |
| Denmark | 3.82% |
Returns the fund reported
2019-09 – 2026-05Monthly total returns from Item B.5 of HDEF's own filings, 81 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference 0.41 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: HDEF.json · all funds.
Who borrows HDEF's shares
2026-05-29The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-29, $47m was out to 7 borrowers, 2.06% of net assets. The largest, BNP PARIBAS SECURITIES CORP, held 67.1% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| BNP PARIBAS SECURITIES CORP | $31m | 67.1% |
| BMO Capital Markets | $5m | 9.8% |
| GOLDMAN SACHS & CO. | $3m | 7.0% |
| MORGAN STANLEY & CO LLC | $3m | 6.5% |
| BARCLAYS CAPITAL INC. | $3m | 5.9% |
Cash collateral reported against the loan: 2.31% of net assets, 112.4% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter HDEF has filed, with each borrower: HDEF.json · all funds.
Since the previous filing
2026-02-27 → 2026-05-29122 positions became 121: 19 added (13.6% of the fund at the later date), 20 dropped (9.3% at the earlier date). Half the sum of all weight changes, a turnover proxy: 16.0%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of HDEF compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-02-27 | 2026-05-29 | Largest decreases | 2026-02-27 | 2026-05-29 |
|---|---|---|---|---|---|
| TOTALENERGIES SE | 3.81% | 4.27% | UNILEVER PLC | 3.87% | 3.07% |
| NESTLE' SA/AG | 4.80% | 5.06% | NOVARTIS AG | 5.81% | 5.05% |
| DBS GROUP HOLDINGS LTD | 2.32% | 2.51% | RECKITT BENCKISER GROUP PLC | 1.36% | 0.98% |
| NATURGY ENERGY GROUP SA | 0.18% | 0.34% | MUENCHENER RUECKVERSICHERUNGS-GESELLSCHAFT AG | 2.07% | 1.71% |
| REPSOL SA | 0.61% | 0.71% | VINCI SA | 1.99% | 1.69% |
| OVERSEA-CHINESE BANKING CORP LTD | 1.39% | 1.48% | IBERDROLA SA | 3.68% | 3.42% |
New: ROCHE HOLDING AG (5.09%), NOVO NORDISK A/S (3.65%), DANONE SA (1.11%), JAPAN TOBACCO INC (1.06%), 3I GROUP PLC (0.74%), DENSO CORP (0.50%). Gone: Roche Holding AG (5.89%), Woodside Energy Group Ltd. (0.93%), Helvetia Baloise Holding AG (0.50%), Obayashi Corp. (0.44%), Mitsui O.S.K. Lines Ltd. (0.31%), Kuehne & Nagel International AG (0.27%).
Asset categories and pricing
as of 2026-05-29| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 92.44% |
| preferred equity EP | 5.24% |
| short-term investment STIV | 2.29% |
| derivative DE | 0.03% |
100.0% of HDEF is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Derivative exposure and counterparties
as of 2026-05-29A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $2.27B. Notional of an interest-rate or currency swap is not equity exposure.
Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of HDEF (41.3). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| SIXH ETC 6 Meridian Hedged Equity-Index Option Strategy ETF | 51 | 41 | 35.35% | 2026-05-31 |
| SPEM State Street(R) SPDR(R) Portfolio Emerging Markets ETF | 2,921 | 41.1 | 26.27% | 2026-06-30 |
| JGLO JPMorgan Global Select Equity ETF | 86 | 41.1 | 39.72% | 2026-07-31 |
| FDLO Fidelity Low Volatility Factor ETF | 126 | 41.1 | 38.49% | 2026-07-31 |
| FDV Federated Hermes U.S. Strategic Dividend ETF | 50 | 41.2 | 34.85% | 2026-07-31 |
| DFAE Dimensional Emerging Core Equity Market ETF | 6,294 | 41.7 | 30.48% | 2026-07-31 |
| PWV Invesco Large Cap Value ETF | 51 | 41.8 | 34.41% | 2026-07-31 |
| XVV iShares ESG Select Screened S&P 500 ETF | 445 | 42 | 40.93% | 2026-06-30 |
| MTUM iShares MSCI USA Momentum Factor ETF | 128 | 42.4 | 40.01% | 2026-07-31 |
| HELO JPMorgan Hedged Equity Laddered Overlay ETF | 156 | 42.4 | 39.41% | 2026-07-31 |
Essays that examine HDEF
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.